Aceto Corporation, together with its consolidated subsidiaries, are referred to herein collectively as “Aceto”, “the Company”, “we”, “us”, and “our”, unless the context indicates otherwise. Aceto was incorporated in 1947 in the State of New York. We are an international company engaged in the development, marketing, sales and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, specialty performance chemicals inclusive of agricultural intermediates and agricultural protection products. Our business is organized along product lines into three principal segments: Human Health, Pharmaceutical Ingredients and Performance Chemicals.
Company profile
Website
CEO
Gilles A. Cottier
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
IRS number
111720520
Latest filings (excl ownership)
15-12G
Securities registration termination
1 Oct 19
S-8 POS
Registration of securities for employees (post-effective amendment)
1 Oct 19
S-8 POS
Registration of securities for employees (post-effective amendment)
1 Oct 19
S-8 POS
Registration of securities for employees (post-effective amendment)
1 Oct 19
S-8 POS
Registration of securities for employees (post-effective amendment)
1 Oct 19
S-8 POS
Registration of securities for employees (post-effective amendment)
1 Oct 19
S-8 POS
Registration of securities for employees (post-effective amendment)
1 Oct 19
8-K
Bankruptcy or Receivership
1 Oct 19
8-K
Bankruptcy or Receivership
20 Sep 19
8-K
Other Events
26 Aug 19
Latest ownership filings
Institutional ownership, Q3 2021
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|